Megmastop 0.03mg/0.15mg Tablet

By Megmastop

Rx

21 Tablet in a Strip

Composition icon

Composition

Ethinyl Estradiol(0.03mg) + Desogestrel(0.15mg)

Manufacturer - Ridhima Biocare icon

Manufacturer - Ridhima Biocare

SCO-30, Cabin No 1, First Floor, Preet Complex, Sector 12-A, Rally, Panchkula,134109, Haryana, India

Expires on or after icon

Expires on or after

July, 2025

About Megmastop 0.03mg/0.15mg Tablet

Megmastop 0.03mg/0.15mg Tablet is a blend of two medications that serve dual purposes - as a contraceptive method to prevent pregnancy and for managing irregular menstrual cycles. This medication works by inhibiting the release of the egg and its fusion with sperm. In addition to its contraceptive benefits, it is also thought to potentially lower the risk of ovarian cancer.

When taking Megmastop 0.03mg/0.15mg Tablet, it can be consumed with or without food, but for optimum results, it should be taken consistently at the same time daily as per your healthcare provider's instructions. The tablet regimen typically begins on the first day of the menstrual cycle and continues for an entire month, with a new pack started immediately after completion. In cases of vomiting within 4 hours of ingestion, the protocol advises taking an additional tablet. Should a dose be missed by more than 12 hours, using a condom during intercourse for the next 2 days is recommended.

Like any medication, Megmastop 0.03mg/0.15mg Tablet may cause some side effects such as nausea, headache, breast pain, and weight gain. If these side effects are bothersome or severe, it is essential to inform your doctor for appropriate guidance. Additionally, instances of spotting or bleeding between periods or missed periods may occur. Persistent or frequent occurrences should be disclosed to your healthcare provider. Any signs of swelling and pain in the limbs, chest discomfort, shortness of breath, or changes in vision should be promptly reported to a healthcare professional as they may signal a blood clot.

Before commencing treatment with this medication, ensure that your doctor is aware of relevant information such as smoking habits, age (especially being over 35), history of heart attack, or cancers of the uterus/cervix, or vagina. Full disclosure of all other medications being taken is necessary as some may interfere with the effectiveness of this drug. Megmastop 0.03mg/0.15mg Tablet should not be used if pregnant or breastfeeding. Regular monitoring of blood pressure, cholesterol, and blood sugar levels may be recommended while undergoing treatment with this medication.


Benefits

Megmastop 0.03mg/0.15mg Tablet is a contraceptive medicine that offers several benefits for women seeking effective birth control methods. By preventing the release of an egg from the ovaries and decreasing sperm movement, Megmastop 0.03mg/0.15mg Tablet disrupts the fertilization process, thereby reducing the chances of pregnancy. This oral hormonal combination drug, containing Desogestrel and Ethinylestradiol, serves as a reliable and safe contraception method when used correctly.


One of the primary benefits of Megmastop 0.03mg/0.15mg Tablet is its convenience and ease of use. Unlike some other birth control methods, Megmastop 0.03mg/0.15mg Tablet does not interfere with sexual activity, allowing individuals to maintain a normal routine without disruptions. The combination of progestin and estrogen in Megmastop 0.03mg/0.15mg Tablet works together to prevent pregnancy in multiple ways. It thickens the fluid in the cervix, making it challenging for sperm to reach the egg, while also inhibiting the thickening of the uterus's inner wall necessary for embryo implantation.


For optimal effectiveness, Megmastop 0.03mg/0.15mg Tablet is typically taken for 21 consecutive days, starting on the first day of the menstrual cycle, followed by a 7-day break before starting the next cycle. This straightforward dosing schedule, when followed as directed by a healthcare provider, ensures the maximum benefits of Megmastop 0.03mg/0.15mg Tablet in preventing unintended pregnancies.


In conclusion, Megmastop 0.03mg/0.15mg Tablet offers a practical and efficient solution for women looking to avoid pregnancy. Its ability to inhibit ovulation and sperm movement, along with its straightforward dosing regimen, makes it a popular choice for contraception. By adhering to the prescribed usage guidelines, individuals can confidently rely on Megmastop 0.03mg/0.15mg Tablet to help them lead a worry-free life while effectively preventing unwanted pregnancies.


How to use the Megmastop 0.03mg/0.15mg Tablet

To use Megmastop 0.03mg/0.15mg Tablet, follow the instructions provided by your doctor carefully. Swallow the tablet whole with a glass of water; do not crush, chew, or break it. It's important to take the tablet as a whole. Megmastop 0.03mg/0.15mg Tablet can be taken with or without food, but try to take it at the same time every day to maintain consistency. Your doctor will advise you on the specific dosage and duration of the treatment with Megmastop 0.03mg/0.15mg Tablet. It's crucial to adhere to the prescribed dose and duration to ensure the medication works effectively. If you have any questions or concerns about how to use Megmastop 0.03mg/0.15mg Tablet, make sure to consult your healthcare provider for further guidance.


Uses of Megmastop 0.03mg/0.15mg Tablet

Megmastop 0.03mg/0.15mg Tablet is commonly used for contraception and to treat dysmenorrhea, which refers to irregular periods. The tablet can help prevent unwanted pregnancies by acting as a form of birth control. Additionally, it can also be effective in regulating menstrual cycles and reducing the severity of menstrual cramps associated with dysmenorrhea. The tablet's dual purpose makes it a versatile option for women looking to manage their reproductive health and menstrual symptoms effectively.


What conditions Megmastop 0.03mg/0.15mg Tablet treats?

Megmastop 0.03mg/0.15mg Tablet is used to prevent pregnancy by keeping the egg and sperm apart, thus avoiding fertilization. It works by stopping egg production and altering the thickness of the uterus wall. Additionally, Novelon can help manage dysmenorrhea, a condition characterized by irregular and painful periods. This may cause abdominal pain, digestive issues, fainting, vomiting, and nausea due to variations in the menstrual cycle, which can be either shorter or longer than the standard 25-30 days.


Should you consult a doctor?

If you experience vomiting within 4 hours of taking Megmastop 0.03mg/0.15mg Tablet, it is advised to take another tablet. If you miss a dose and are more than 12 hours late, it is recommended to use a condom during intercourse for the next 2 days. Consult your doctor if you notice spotting or bleeding between menstrual periods, missed periods, or persistent symptoms like swelling and pain in limbs, shortness of breath, chest pain, or changes in vision, as these could indicate complications that require medical attention.


Additionally, inform your doctor if you have a history of smoking and are older than 35, had a heart attack, or have had cancer of the uterus, cervix, or vagina. It is essential to keep your doctor informed about all medications you are taking to avoid any negative interactions. Regular monitoring of blood pressure, cholesterol, and blood sugar levels may also be necessary during treatment. Remember not to use this medication if you are already pregnant or breastfeeding.


Side effects of Megmastop 0.03mg/0.15mg Tablet

When taking Novelon tablets, some users may experience mild side effects that typically fade as the body gets used to the medication. These side effects include nausea, stomach pain, headaches, irregular uterine bleeding, weight gain, and breast pain. Headaches, weight gain, acne, abdominal pain, cramps, breast pain, and depression are also reported side effects with Novelon tablets. If these side effects persist or cause concern, it is advisable to consult with a healthcare professional.


Safety advice

scroll

liver

When using Megmastop 0.03mg/0.15mg Tablet, caution is advised for patients with liver disease. It may be necessary to adjust the dose of Megmastop 0.03mg/0.15mg Tablet in such cases. It is important to consult your doctor before taking this medication. Patients with severe liver disease or active liver disease are not recommended to use Megmastop 0.03mg/0.15mg Tablet.

scroll

kidney

Limited information is available on using Megmastop 0.03mg/0.15mg Tablet in patients with kidney disease. Consult your doctor for advice before using.

scroll

alcohol

When taking Megmastop 0.03mg/0.15mg Tablet, it is important to be cautious when drinking alcohol. Consult your doctor for guidance on alcohol consumption while on this medication.

scroll

driving

It's generally safe to drive while taking Megmastop 0.03mg/0.15mg Tablet as it does not typically impact driving abilities.

scroll

pregnancy

During pregnancy, it is not safe to use Megmastop 0.03mg/0.15mg Tablet. Studies have found harmful effects on developing babies. Consult your doctor for guidance.

scroll

breastfeeding

Megmastop 0.03mg/0.15mg Tablet should not be used while breastfeeding due to potential toxicity to the baby. It is recommended to consider nonhormonal or progestin-only contraceptives, particularly in the first 4 weeks postpartum.


Consumption warning before consuming Megmastop 0.03mg/0.15mg Tablet

Before consuming Megmastop 0.03mg/0.15mg Tablet, it is crucial to inform your doctor about any history of heart disease, hypertension, obesity, cancer (breast, cervix, or uterus), diabetes mellitus, liver or kidney disease, or abnormal uterine bleeding. Women over 35 years should be cautious, as smoking can raise the risk of a cardiovascular event while using Megmastop 0.03mg/0.15mg Tablet. Remember, this medication does not safeguard against sexually transmitted diseases or HIV. If you become pregnant while taking Megmastop 0.03mg/0.15mg Tablet, seek medical advice promptly. Refrain from starting any new medication without consulting your doctor. Spotting or bleeding between periods may occur, contact your doctor if the spotting persists. Do not use Megmastop 0.03mg/0.15mg Tablet if pregnant or recently delivered a baby. In case of a missed dose, use condoms during intercourse for 5 days to prevent pregnancy. Moreover, if you have migraines, notify your doctor as this medication could exacerbate headaches.


What if you forgot to take Megmastop 0.03mg/0.15mg Tablet?

If you happen to miss a dose of Megmastop 0.03mg/0.15mg Tablet, it's important to consult with your doctor for guidance. Keeping open communication with your healthcare provider is vital in maintaining the effectiveness of your treatment. By seeking advice on what steps to take next, you can ensure that you stay on track with your medication regimen. Remember, your doctor is there to support you in managing your health, so don't hesitate to reach out in case you miss a dose of Megmastop 0.03mg/0.15mg Tablet.


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic ClassGYNAECOLOGICAL
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

175

Inclusive of all taxes

Content verified by

chevron-right

Dr. Gowri Kulkarni

MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)

Last update on 18-Nov-2024